Sarepta Therapeutics
SRPT
SRPT
340 hedge funds and large institutions have $5.52B invested in Sarepta Therapeutics in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 128 increasing their positions, 101 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
23% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 95
38% less funds holding in top 10
Funds holding in top 10: 13 → 8 (-5)
49% less capital invested
Capital invested by funds: $10.9B → $5.52B (-$5.35B)
Holders
340
Holding in Top 10
8
Calls
$232M
Puts
$241M
Top Buyers
| 1 | +$62.7M | |
| 2 | +$53M | |
| 3 | +$52.5M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$48.3M |
| 5 |
BlackRock
New York
|
+$43.9M |
Top Sellers
| 1 | -$191M | |
| 2 | -$85.6M | |
| 3 | -$83.1M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$76M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$62.6M |